Vitamin D and fat

Vitamin D

Volumn , Issue , 2011, Pages 769-776

  De Paula, Francisco J A ^a   Rosen, Clifford J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884737292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10044-7     Document Type: Chapter

References (70)

1. Holick M.F. Vitamin D: a millennium perspective. J. Cell Biochem. 2003, 88(2):296-307.
2. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., et al. Vitamin D and prevention of colorectal cancer. J. Steroid Biochem. Mol. Biol. 2005, 97(1-2):179-194.
3. Krishnan A.V., Trump D.L., Johnson C.S., Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol. Metab. Clin. North Am. 2010, 39(2):401-418.
4. 3 is a negative endocrine regulator of the rennin-angiotensin sytem. J. Clin. Invest. 2002, 110(2):229-238.
5. Rostand S.G. Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis. Clin. J. Am. Soc. Nephrol. 2010, 5(9):1697-1703.
6. Verhave G., Siegert C.E. Role of vitamin D in cardiovascular disease. Neth. J. Med. 2010, 68(3):113-118.
7. Zhao G., Simpson R.U. Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes. J. Steroid Biochem. Mol. Biol. 2010, 121(1-2):159-163.
8. Fernandes de Abreu D.A., Eyles D., Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009, 34(Suppl. 1):S265-S277.
9. Deluca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001, 15(14):2579-2585.
10. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. BMJ 2009, 339:b3692.
11. Moreira-Pfrimer L.D., Pedrosa M.A., Teixeira L., Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann. Nutr. Metab. 2009, 54(4):291-300.
12. Gilsanz V., Kremer A., Mo A.O., Wren T.A., Kremer R. Vitamin D status and its relation to muscle mass and muscle fat in young women. J. Clin. Endocrinol. Metab. 2010, 95(4):1595-1601.
13. Keisala T., Minasyan A., Lou Y.R., Zou J., Kalueff A.V., Pyykkö I., Tuohimaa P. Premature aging in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 2009, 115(3-5):91-97.
14. Lanske B., Razzaque M.S. Vitamin D and aging: old concepts and new insights. J. Nutr. Biochem. 2007, 18(12):771-777.
15. Beydoun M.A., Boueiz A., Shroff M.R., Beydoun H.A., Wang Y., Zonderman A.B. Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J. Clin. Endocrinol. Metab. 2010, 95(8):3814-3827.
16. Brock K., Huang W.Y., Fraser D.R., Ke L., Tseng M., Stolzenberg-Solomon R., et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J. Steroid Biochem. Mol. Biol. 2010, 121(1-2):462-466.
17. Hollis B.W. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol. Metab. Clin. North Am. 2010, 39(2):271-286.
18. Kennel K.A., Drake M.T., Hurley D.L. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin. Proc. 2010, 85(8):752-757.
19. Christakos S., Ajibade D.V., Dhawan P., Fechner A.J., Mady L.J. Vitamin D: metabolism. Endocrinol. Metab. Clin. North Am. 2010, 39(2):243-253.
20. Brouwer D.A., van Beek J., Ferwerda H., Brugman A.M., van der Klis F.R., van der Heiden H.J., et al. Rat adipose tissue rapidly accumulates and slowly releases an orally administered high vitamin D dose. Br. J. Nutr. 1998, 79(6):527-532.
21. Pike J.W., Meyer M.B. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol. Metab. Clin. North. Am. 2010, 39(2):271-286.
22. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357(3):266-281.
23. Verstuyf A., Carmeliet G., Bouillon R., Mathieu C. Vitamin D, a pleiotropic hormone. Kidney Int. 2010, 78(2):140-145.
24. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 2010, 39(2):365-379.
25. Zemel M.B. Role of calcium and dairy products in energy partitioning and weight management. Am. J. Clin. Nutr. 2004, 79(5):907S-912S.
26. Holmén J., Jansson A., Larsson D. A kinetic overview of the receptors involved in 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 signaling: a systems biology approach. Crit. Rev. Eukaryot. Gene Expr. 2009, 19(3):181-196.
27. Paula F.J., Bornstein S., Paula I.D., Le P., Rostama B., Rosen C.J. Heterozygosity in the VDR gene influences body composition more than bone mass. ASBMR 2010 Annual Meeting, Toronto 2010, SAO117.
28. Picot J., Jones J., Colquitt J.L., Gospodarevskaya E., Loveman E., Baxter L., et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol. Assess. 2009, 13(41):1-190.
29. Du H., Feskens E. Dietary determinants of obesity. Acta Cardiol. 2010, 65(4):377-386.
30. Foster G.D., Wyatt H.R., Hill J.O., Makris A.P., Rosenbaum D.L., Brill C., et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann. Intern. Med. 2010, 153(3):147-157.
31. Vasconcellos R.S., Borges N.C., Gonçalves K.N., Canola J.C., de Paula F.J., Malheiros E.B., et al. Protein intake during weight loss influences the energy required for weight loss and maintenance in cats. J. Nutr. 2009, 139(5):855-860.
32. Eller L.K., Reimer R.A. Dairy protein attenuates weight gain in obese rats better than whey or casein alone. Obesity (Silver Spring) 2010, 18(4):704-711.
33. Pilvi T.K., Harala S., Korpela R., Mervaala E.M. Effects of high-calcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL/6J mice. Br. J. Nutr. 2009, 102(3):337-341.
34. Kelishadi R., Zemel M.B., Hashemipour M., Hosseini M., Mohammadifard N., Poursafa P. Can a dairy-rich diet be effective in long-term weight control of young children?. J. Am. Coll. Nutr. 2009, 28(5):601-610.
35. Zemel M.B. Proposed role of calcium and dairy food components in weight management and metabolic health. Phys. Sportsmed. 2009, 37(2):29-39.
36. Shi H., Norman A.W., Okamura W.H., Sen A., Zemel M.B. 1alpha,25Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 2001, 15:2751-2753.
37. Zemel M.B., Kim J.H., Woychik R.P., Michaud E.J., Kadwell S.H., Patel I.R., et al. Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA 1995, 92(11):4733-4737.
38. Shi H., Norman A.W., Okamura W.H., Sen A., Zemel M.B. 1Alpha,25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J. 2002, 16(13):1808-1810.
39. Xue B., Greenberg A.G., Kraemer F.B., Zemel M.B. Mechanism of intracellular calcium inhibition of lipolysis in human adipocytes. FASEB J. 2001, 15(13):2527-2529.
40. Zemel M.B., Shi H., Greer B., DiRienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J. 2000, 14(9):1132-1138.
41. Moussa N.M., Claycombe K.J. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity. Obes. Res. 1999, 7(5):506-514.
42. Smith S.R., Gawronska-Kozak B., Janderová L., Nguyen T., Murrell A., Stephens J.M., et al. Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes. Diabetes 2003, 52(12):2914-2922.
43. Zemel M.B., Kim J.H., Woychik R.P., Michaud E.J., Kadwell S.H., Patel I.R., et al. Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA 1995, 92(11):4733-4737.
44. Kim J.H., Kiefer L.L., Woychik R.P., Wilkison W.O., Truesdale A., Ittoop O., et al. Agouti regulation of intracellular calcium: role of melanocortin receptors. Am. J. Physiol. 1997, 272(3 Pt 1):E379-E384.
45. Xue B.Z., Moustaid N., Wilkison W.O., Zemel M.B. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J. 1998, 12:1391-1396.
46. Xue B., Zemel M.B. Relationship between human adipose tissue agouti and fatty acid synthase (FAS). J. Nutr. 2000, 130(10):2478-2481.
47. Zemel M.B., Sun X. Calcitriol and energy metabolism. Nutr. Rev. 2008, 10(suppl. 2):S139-S146.
48. Zinser G.M., Welsh J. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 2004, 25(12):2361-2372.
49. Guzey M., Jukic D., Arlotti J., Acquafondata M., Dhir R., Getzenberg R.H. Increased apoptosis of periprostatic adipose tissue in VDR null mice. J. Cell Biochem. 2004, 193(1):133-141.
50. Narvaez C.J., Matthews D., Broun E., Chan M., Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 2009, 150(2):651-661.
51. Wong K.E., Szeto F.L., Zhang W., Ye H., Kong J., Zhang Z., et al. Involvement of vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am. J. Physiol. Endocrinol. Metab. 2008, 296(4). E820:E828.
52. Gong D.W., He Y., Karas M., Reitman M. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J. Biol. Chem. 1997, 272(39):24129-24132.
53. Rohlfs E.M., Daniel K.W., Premont R.T., Kozak L.P., Collins S. Regulation of the uncoupling protein gene (Ucp) by beta 1, beta 2, and beta 3-adrenergic receptor subtypes in immortalized brown adipose cell lines. J. Biol. Chem. 1995, 270(18):10723-10732.
54. Baynes K.C., Boucher B.J., Feskens E.J., Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997, 40(3):344-347.
55. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 2004, 79(5):820-825.
56. Cade C., Norman A.W. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986, 119(1):84-90.
57. Arunabh S., Pollack S., Yeh J., Aloia J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. 2003, 88(1):157-161.
58. Worstman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000, 72(3):690-693.
59. Zhou J., Zhao L.J., Watson P., Zhang Q., Lape J.M. The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr. Metab. (Lond.) 2010; Jul 23, 7:62.
60. Reinehr T., de Sousa G., Alexy U., Kersting M., Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur. J. Endocrinol. 2007, 157(2):225-232.
61. Alemzadeh R., Kichler J., Babar G., Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008, 57(2):183-191.
62. Hey H., Stokholm K.H., Lund B., Lund B., Sørensen O.H. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int. J. Obes. 1982, 6(5):473-479.
63. Nimitphong H., Chanprasertyothin S., Jongjaroenprasert W., Ongphiphadhanakul B. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009, 36(2):205-210.
64. Paula F.J., Rosen C.J. Obesity, diabetes mellitus and last but not least, osteoporosis. Arq. Bras. Endocrinol. Metabol. 2010, 54(2):150-157.
65. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic bone diseases in wild-type mice. Proc. Natl. Acad. Sci. 2008, 105(13):5266-5270.
66. Vestri H.S., Lara-Castro C., Moellering D.R., Gunberg C.M., Garvey W.T. Osteocalcin is not just for bones: effects on adipocytes and role in human metabolism. Diabetes 2008, 57:A29.
67. Rached M.T., Kode A., Silva B.C., Jung D.Y., Gray S., Ong H., et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 2010, 120(1):357-368.
68. Ferron M., Wei J., Yoshikawa T., Del Fattore A., DePinho R.A., Teti A., et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142(2):296-308.
69. Fulzele K., Riddle R.C., Digirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142(2):309-319.
70. Rosen C.J., Motyl K.J. No bones about it: insulin modulates skeletal remodeling. Cell 2010, 142(2):198-200.